Colon Adenocarcinoma Clinical Trials

48 clinical trials for Colon Adenocarcinoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) — RECRUITING · PHASE3
• Family Communications After Genetic Testing — RECRUITING · NA
• COLON ERDERLY LOW DOSE — RECRUITING
• Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas — RECRUITING · PHASE1
• Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma — RECRUITING · PHASE2
• Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma — RECRUITING · NA
• LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis — RECRUITING · NA
• Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test — RECRUITING
• Evaluating Novel Therapies in ctDNA Positive GI Cancers — RECRUITING · PHASE3
• Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection — RECRUITING · NA
• Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. — RECRUITING · PHASE2
• HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer — RECRUITING · PHASE2
• Estudio aleatorizado fase III multicéntrico sobre la eficacia de las infusiones de calcio y magnesio en la prevención de la neurotoxicidad inducida por el tratamiento adyuvante del cáncer de colon — ACTIVE_NOT_RECRUITING · PHASE3
• Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair — ACTIVE_NOT_RECRUITING · PHASE3
• Impact of Probiotics on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer. — NOT_YET_RECRUITING · NA
• Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Improving Prognostication in Colon Cancer — NOT_YET_RECRUITING
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Young-Onset Colorectal Cancer — ACTIVE_NOT_RECRUITING
• Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery — COMPLETED · PHASE2
• Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) — COMPLETED · NA
• Comparison of Laparoscopic and Open Total Mesocolic Excision With Central Vascular Ligation for Right Colon Carcinoma — NOT_YET_RECRUITING · NA
• PeLear CCC: Proyecto Latino Contra Cancer Colorrectal — COMPLETED · NA
• Study of the Immune Response in Colon Adenocarcinoma — COMPLETED
• Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery — COMPLETED
• Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy — COMPLETED
• Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer — COMPLETED · PHASE2
• Current Microsatellite Stability Results in Colon Cancer — NOT_YET_RECRUITING
• Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability — COMPLETED · PHASE1
• Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection — COMPLETED · NA
• Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study — OTHER · PHASE2
• The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery — COMPLETED · NA
• Peptide-based Immunization for Colon- and and Pancreas-carcinoma — COMPLETED
• Role of Immunoscore® in Stage II-III Colorectal Cancer — OTHER
• Validation of Aer-O-Scope Colonoscope System Cecal Intubation — COMPLETED · NA
• The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon — COMPLETED · NA
• Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer — COMPLETED · PHASE1
• Molecular Profiling of Colorectal Cancer — OTHER
• Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy — COMPLETED · NA
• Whole-Exome Sequencing (WES) of Cancer Patients — COMPLETED
• Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older — COMPLETED
• Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth — OTHER · NA
• Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial — OTHER · PHASE2
• Audit of Surgery for Colorectal Cancer — COMPLETED
• Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer — COMPLETED · PHASE3
• Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer — WITHDRAWN · PHASE1

Refine this search